BR0102138B1 - formulaÇço oftÁlmica aquosa para o tratamento e prevenÇço de infecÇÕes, e, uso de um quitosano. - Google Patents

formulaÇço oftÁlmica aquosa para o tratamento e prevenÇço de infecÇÕes, e, uso de um quitosano.

Info

Publication number
BR0102138B1
BR0102138B1 BRPI0102138-9A BR0102138A BR0102138B1 BR 0102138 B1 BR0102138 B1 BR 0102138B1 BR 0102138 A BR0102138 A BR 0102138A BR 0102138 B1 BR0102138 B1 BR 0102138B1
Authority
BR
Brazil
Prior art keywords
chitosan
prevention
treatment
infections
ophthalmic formulation
Prior art date
Application number
BRPI0102138-9A
Other languages
English (en)
Other versions
BR0102138A (pt
Inventor
Robert Gurny
Olivia Mireille Felt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR0102138A publication Critical patent/BR0102138A/pt
Publication of BR0102138B1 publication Critical patent/BR0102138B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
BRPI0102138-9A 2000-05-26 2001-05-25 formulaÇço oftÁlmica aquosa para o tratamento e prevenÇço de infecÇÕes, e, uso de um quitosano. BR0102138B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00111377A EP1157688B1 (en) 2000-05-26 2000-05-26 Antibacterial aqueous ophthalmic formulations containing ofloxacin and chitosan

Publications (2)

Publication Number Publication Date
BR0102138A BR0102138A (pt) 2002-03-12
BR0102138B1 true BR0102138B1 (pt) 2013-03-19

Family

ID=8168851

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0102138-9A BR0102138B1 (pt) 2000-05-26 2001-05-25 formulaÇço oftÁlmica aquosa para o tratamento e prevenÇço de infecÇÕes, e, uso de um quitosano.

Country Status (11)

Country Link
US (1) US6589999B2 (pt)
EP (1) EP1157688B1 (pt)
AT (1) ATE238767T1 (pt)
BR (1) BR0102138B1 (pt)
CA (1) CA2346631C (pt)
CZ (1) CZ299195B6 (pt)
DE (1) DE60002448T2 (pt)
DK (1) DK1157688T3 (pt)
ES (1) ES2195819T3 (pt)
PL (1) PL201564B1 (pt)
PT (1) PT1157688E (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716970B2 (en) 2000-04-21 2004-04-06 Adjuvant Pharmaceuticals, Llc Water soluble, randomly substituted partial N-partial O-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof
US7125967B2 (en) * 2003-10-08 2006-10-24 Adjuvant Pharmaceuticals, Llc Water-soluble chitosan having low endotoxin concentration and methods for making and using the same
US7125122B2 (en) * 2004-02-02 2006-10-24 Sharp Laboratories Of America, Inc. Projection system with corrective image transformation
US20060287278A1 (en) * 2005-06-21 2006-12-21 Zhenze Hu Method for improving water solubility of chitosan
CN100350978C (zh) * 2005-07-12 2007-11-28 何伟 可载药的降解型泪道栓子及其制备方法
FR3016882A1 (fr) 2014-01-30 2015-07-31 Sofradim Production Procede de preparation de chitosane a haut degre d’acetylation
EP3369422A4 (en) * 2015-10-29 2018-12-05 Teika Pharmaceutical Co., Ltd. External preparation
CN109846820B (zh) * 2019-04-09 2020-09-29 广东三蓝药业股份有限公司 一种氧氟沙星滴眼液及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH675535A5 (pt) * 1988-11-28 1990-10-15 Nestle Sa
US5422116A (en) * 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system
AU1169999A (en) * 1998-11-20 2000-06-13 Laboratoire Medidom S.A. Aqueous ophthalmic formulations comprising chitosan

Also Published As

Publication number Publication date
ES2195819T3 (es) 2003-12-16
CA2346631C (en) 2008-12-02
DE60002448T2 (de) 2004-03-25
CA2346631A1 (en) 2001-11-26
EP1157688B1 (en) 2003-05-02
EP1157688A1 (en) 2001-11-28
DE60002448D1 (de) 2003-06-05
US20020002148A1 (en) 2002-01-03
ATE238767T1 (de) 2003-05-15
CZ299195B6 (cs) 2008-05-14
DK1157688T3 (da) 2003-08-25
PL347735A1 (en) 2001-12-03
US6589999B2 (en) 2003-07-08
CZ20011784A3 (cs) 2002-02-13
PT1157688E (pt) 2003-08-29
BR0102138A (pt) 2002-03-12
PL201564B1 (pl) 2009-04-30

Similar Documents

Publication Publication Date Title
WO2002051464A3 (en) Antimicrobial medical devices
TR200302105T4 (tr) Siklosporin, hiyalüronik asit ve polisorbat içeren göz formülasyonları.
CA2378424A1 (en) Moxifloxacin formulation containing common salt
PT90124A (pt) Processo para a preparacao de composicoes farmaceuticas de piroxicamo em solucoes aquosas
HUP0302161A2 (hu) Vizes fertżtlenítż rendszerek
BR0102138B1 (pt) formulaÇço oftÁlmica aquosa para o tratamento e prevenÇço de infecÇÕes, e, uso de um quitosano.
IT1305313B1 (it) 3,4 - diidro- 6- benzil-4-oxopirimidine sostituite e relativo processodi produzione e impiego nella terapia delle infezioni da hiv-1.
GR3032116T3 (en) A method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans
WO2003082926A3 (en) Antimicrobial polymer conjugates
BR0311874A (pt) Uso de nefopam para o tratamento de náusea ou emese
DK1128809T3 (da) Vandige oftalmiske formuleringer omfattende chitosan
BR0210632A (pt) Tratamento de doença parasìtica
WO2002000208A3 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
SE0001916D0 (sv) Novel formulation
BR0115983A (pt) Uso de sarp-1 para o tratamento e/ou prevenção de escleroderma
WO2002039992A3 (en) Adducts of quinolonic agents with natural polysaccharide polymers
RU2001100069A (ru) Антгельминтное средство
WO2001097774A3 (de) Neue pharmazeutische zusammensetzung zur topischen anwendung von wasserunlöslichen und/oder schwer wasserlöslichen wirkstoffen
BR0108458B1 (pt) biopolìmero sob forma seca, dispersìvel e com hidratação rápida, utilização do mesmo, e, formulação.
AU4975700A (en) Absorbent article comprising topsheet with low surfactant or no synthetic surfactant
WO2002002115A3 (de) Anthelmintika zur verhinderung von parasitären infektionen bei mensch und tier
WO2002002089A3 (de) Anthelminthika zur verhinderung von parasitären infektionen bei mensch und tier iv
SE9902673D0 (sv) New composition
BR0106909A (pt) Composições para cuidado pessoal

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]

Free format text: DE ACORDO COM ART. 34 " II " DA LPI ( LEI 9279, DE 14/05/96 ), O EXAME FICA SUSPENSO PARA QUE O REQUERENTE APRESENTE DOCUMENTOS NECESSARIOS A REGULARIZACAO DO PROCESSO E EXAME DO PEDIDO.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 19/03/2013, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 15A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.